Autopsy report · NCT00016276

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Administratively complete.”

The sponsor’s own words in the registry.

Life of this trial

396 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 3
Sponsor: National Cancer Institute (NCI)
Sponsor type: US National Institutes of Health
Conditions: Cardiac Toxicity; Inflammatory Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IV Breast Cancer
Interventions: dexrazoxane hydrochloride; doxorubicin hydrochloride; cyclophosphamide; paclitaxel; trastuzumab; therapeutic conventional surgery
Participants: 396
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.